Community of the Good Shepherd
The Community of The Good Shepherd positively affects the lives of adults with developmental disabilities by providing a high-quality, modern, family-like residential and daycare environment. The Community of The Good Shepherd's programs create optimum opportunities for self-development and personal satisfaction.
ICO
430903057
Web
Sign in to see organisation website
Address
Kansas City
From Social media
News about from their social media (Facebook and X).
Data about organisation
Kansas City
Organisations from Community of the Good Shepherd
1. American Cancer Society, Kansas City
For cancer information, call 1-800-227-2345 or visit cancer.
2. INTERNATIONAL HOUSE OF PRAYER
24/7 Prayer.
3. GASHLAND (KANSAS CITY) UNITED METHODIST CHURCH
The United Methodist Church is a worldwide connection of close to 10 million members in over 100 countries including Africa, Asia, Europe and the United States.
4. Centennial (Kansas City) United Methodist Church
The United Methodist Church is a worldwide connection of close to 10 million members in over 100 countries including Africa, Asia, Europe and the United States.
5. COUNTRY CLUB (KANSAS CITY) UNITED METHODIST CHURCH
The United Methodist Church is a worldwide connection of close to 10 million members in over 100 countries including Africa, Asia, Europe and the United States.
Interesting nearby
Interesting organisations close by to residence of Community of the Good Shepherd
We offer mental health and substance use treatment services to Kansas City community members in need.
Developing Potential is a nationally accredited, nonprofit organization providing quality services an.
Center for Developmentally Disabled
CDD is a 501(c)(3) non-profit organization that provides housing, residential care, day habilitation.
Join us and make a difference for the future!
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News
Exciting news from ITM! 🚀 Their Phase 3 COMPETE trial shows promising results for n.c.a. 177Lu-edotreotide, offering hope for patients with GEP-NETs. Together, we're witnessing advancements in healthcare that make a real difference! 💪💙 #CancerResearch #Hope #PositiveNews
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025
StreetInsider.com
Like Comment